Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Horvath, K; Jeitler, K; Siering, U; Stich, AK; Skipka, G; Gratzer, TW; Siebenhofer, A.
Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis.
ARCH INTERN MED. 2008; 168(6): 571-580.
Doi: 10.1001/archinte.168.6.571
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Horvath Karl
- Co-authors Med Uni Graz
-
Jeitler Klaus
-
Siebenhofer-Kroitzsch Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Weight loss is recommended in all major guidelines for antihypertensive therapy. We searched for randomized controlled trials investigating the effects of weight-reducing diets, pharmacologic substances, and invasive interventions for weight reduction on patient-relevant end points and blood pressure (BP) in patients with essential hypertension. No information on the effects on patient-relevant end points was available. Patients assigned to weight loss diets, orlistat, or sibutramine reduced their body weight more effectively than did patients in the usual care/placebo groups. Reduction of BP was higher in patients treated with weight loss diets (systolic BP [SBP]: weighted mean difference [WMD], -6.3 mm Hg; diastolic BP [DBP]: WMD, -3.4 mm Hg) or orlistat (SBP: WMD, -2.5 mm Hg; DBP: WMD, -2.0 mm Hg). Systolic BP increased with sibutramine treatment (WMD, 3.2 mm Hg). In patients with essential hypertension, therapy with a weight loss diet or orlistat resulted in reductions in body weight and BP. Although sibutramine treatment reduced body weight, it did not lower BP.
- Find related publications in this database (using NLM MeSH Indexing)
-
Appetite Depressants - therapeutic use
-
Blood Pressure - drug effects
-
Cyclobutanes - therapeutic use
-
Humans -
-
Hypertension - complications
-
Lactones - therapeutic use
-
Obesity - complications
-
Time Factors -
-
Treatment Outcome -
-
Weight Loss - drug effects